FTVFX
Price
$42.89
Change
+$0.29 (+0.68%)
Updated
Sep 11 closing price
Net Assets
408.8M
MVCAX
Price
$34.27
Change
+$0.08 (+0.23%)
Updated
Sep 11 closing price
Net Assets
16.78B
Interact to see
Advertisement

FTVFX vs MVCAX

FTVFX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
FTVFX vs. MVCAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTVFX is a Hold and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.8B vs. FTVFX (409M). MVCAX pays higher dividends than FTVFX: MVCAX (1.08) vs FTVFX (0.63). FTVFX was incepted earlier than MVCAX: FTVFX (23 years) vs MVCAX (25 years). FTVFX (1.32) is less costly to investors than MVCAX (0.98). FTVFX is a more actively managed with annual turnover of: 68.00 vs. MVCAX (24.00). MVCAX initial investment is less costly to investors than FTVFX (4%) vs FTVFX (4%). FTVFX has a lower initial minimum investment than MVCAX: FTVFX (0) vs MVCAX (1000). FTVFX annual gain was more profitable for investors over the last year : 16.74 vs. MVCAX (5.51). FTVFX return over 5 years is better than : 37.47 vs. MVCAX (15.15).
FTVFXMVCAXFTVFX / MVCAX
Total Expense Ratio1.320.97136%
Annual Report Gross Expense Ratio1.320.98135%
Fund Existence23 years25 years-
Gain YTD21.40212.903166%
Front Load4%6%61%
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets409M16.8B2%
Annual Yield % from dividends0.631.0858%
Returns for 1 year16.745.51304%
Returns for 3 years36.0923.61153%
Returns for 5 years37.4715.15247%
Returns for 10 years106.8183.46128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEI14.651.06
+7.80%
Methode Electronics
PENG51.162.54
+5.22%
Penguin Solutions Inc
LNZA6.110.23
+3.91%
LanzaTech Global Inc
SMMT17.550.55
+3.24%
Summit Therapeutics
RNAZ1.69N/A
N/A
TransCode Therapeutics Inc